As of 2023, the production value of ozone therapy, oxygen therapy, aerosol therapy, and respiration apparatus in France was stable. With forecasted values starting from 128.95 million euros in 2024, this industry reveals a slight year-on-year increase, reaching 131.22 million euros by 2028. The growth pattern from 2024 to 2028 shows a steady annual increase, roughly translating to a CAGR of around 0.5%, suggesting a relatively slow yet consistent market expansion.
Future trends to watch for include technological advancements in medical respiratory devices, increased demand from aging populations, and potential policy changes impacting healthcare spending, which could accelerate the market's growth pace.
